Cargando…

Frequency of Drug Resistance Gene Amplification in Clinical Leishmania Strains

Experimental studies about Leishmania resistance to metal and antifolates have pointed out that gene amplification is one of the main mechanisms of drug detoxification. Amplified genes code for adenosine triphosphate-dependent transporters (multidrug resistance and P-glycoproteins P), enzymes involv...

Descripción completa

Detalles Bibliográficos
Autores principales: Mary, C., Faraut, F., Deniau, M., Dereure, J., Aoun, K., Ranque, S., Piarroux, R.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2913627/
https://www.ncbi.nlm.nih.gov/pubmed/20706666
http://dx.doi.org/10.1155/2010/819060
_version_ 1782184681393881088
author Mary, C.
Faraut, F.
Deniau, M.
Dereure, J.
Aoun, K.
Ranque, S.
Piarroux, R.
author_facet Mary, C.
Faraut, F.
Deniau, M.
Dereure, J.
Aoun, K.
Ranque, S.
Piarroux, R.
author_sort Mary, C.
collection PubMed
description Experimental studies about Leishmania resistance to metal and antifolates have pointed out that gene amplification is one of the main mechanisms of drug detoxification. Amplified genes code for adenosine triphosphate-dependent transporters (multidrug resistance and P-glycoproteins P), enzymes involved in trypanothione pathway, particularly gamma glutamyl cysteine synthase, and others involved in folates metabolism, such as dihydrofolate reductase and pterine reductase. The aim of this study was to detect and quantify the amplification of these genes in clinical strains of visceral leishmaniasis agents: Leishmania infantum, L. donovani, and L. archibaldi. Relative quantification experiments by means of real-time polymerase chain reaction showed that multidrug resistance gene amplification is the more frequent event. For P-glycoproteins P and dihydrofolate reductase genes, level of amplification was comparable to the level observed after in vitro selection of resistant clones. Gene amplification is therefore a common phenomenon in wild strains concurring to Leishmania genomic plasticity. This finding, which corroborates results of experimental studies, supports a better understanding of metal resistance selection and spreading in endemic areas.
format Text
id pubmed-2913627
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-29136272010-08-12 Frequency of Drug Resistance Gene Amplification in Clinical Leishmania Strains Mary, C. Faraut, F. Deniau, M. Dereure, J. Aoun, K. Ranque, S. Piarroux, R. Int J Microbiol Research Article Experimental studies about Leishmania resistance to metal and antifolates have pointed out that gene amplification is one of the main mechanisms of drug detoxification. Amplified genes code for adenosine triphosphate-dependent transporters (multidrug resistance and P-glycoproteins P), enzymes involved in trypanothione pathway, particularly gamma glutamyl cysteine synthase, and others involved in folates metabolism, such as dihydrofolate reductase and pterine reductase. The aim of this study was to detect and quantify the amplification of these genes in clinical strains of visceral leishmaniasis agents: Leishmania infantum, L. donovani, and L. archibaldi. Relative quantification experiments by means of real-time polymerase chain reaction showed that multidrug resistance gene amplification is the more frequent event. For P-glycoproteins P and dihydrofolate reductase genes, level of amplification was comparable to the level observed after in vitro selection of resistant clones. Gene amplification is therefore a common phenomenon in wild strains concurring to Leishmania genomic plasticity. This finding, which corroborates results of experimental studies, supports a better understanding of metal resistance selection and spreading in endemic areas. Hindawi Publishing Corporation 2010 2010-07-12 /pmc/articles/PMC2913627/ /pubmed/20706666 http://dx.doi.org/10.1155/2010/819060 Text en Copyright © 2010 C. Mary et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Mary, C.
Faraut, F.
Deniau, M.
Dereure, J.
Aoun, K.
Ranque, S.
Piarroux, R.
Frequency of Drug Resistance Gene Amplification in Clinical Leishmania Strains
title Frequency of Drug Resistance Gene Amplification in Clinical Leishmania Strains
title_full Frequency of Drug Resistance Gene Amplification in Clinical Leishmania Strains
title_fullStr Frequency of Drug Resistance Gene Amplification in Clinical Leishmania Strains
title_full_unstemmed Frequency of Drug Resistance Gene Amplification in Clinical Leishmania Strains
title_short Frequency of Drug Resistance Gene Amplification in Clinical Leishmania Strains
title_sort frequency of drug resistance gene amplification in clinical leishmania strains
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2913627/
https://www.ncbi.nlm.nih.gov/pubmed/20706666
http://dx.doi.org/10.1155/2010/819060
work_keys_str_mv AT maryc frequencyofdrugresistancegeneamplificationinclinicalleishmaniastrains
AT farautf frequencyofdrugresistancegeneamplificationinclinicalleishmaniastrains
AT deniaum frequencyofdrugresistancegeneamplificationinclinicalleishmaniastrains
AT dereurej frequencyofdrugresistancegeneamplificationinclinicalleishmaniastrains
AT aounk frequencyofdrugresistancegeneamplificationinclinicalleishmaniastrains
AT ranques frequencyofdrugresistancegeneamplificationinclinicalleishmaniastrains
AT piarrouxr frequencyofdrugresistancegeneamplificationinclinicalleishmaniastrains